News|Articles|February 3, 2026

7 Allergy Headlines You Missed in January 2026

FDA clears pediatric HAE oral therapy as intranasal epinephrine and heat-treated peanut/egg OIT studies point to safer allergy care.

January brought several noteworthy updates in allergy research, pediatric care, and immunotherapy. From US Food & Drug Administration (FDA) approvals to innovative approaches in oral immunotherapy (OIT), the month highlighted advances that could meaningfully improve patient safety and quality of life.